EarningsQ3 2023 Earnings Report

Filana Therapeutics (FLNA) Q3 2023 Earnings Report

0 Followers

MX:FLNA Q3 2023 EPS Results

Actual EPS-$10.98

Consensus EPS-$13.95

Beat/MissBeat by +$2.97

One Year Ago EPS-$9.18

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ3 2023

Date11/07/2023

TimeBefore Open

Conference CallTuesday, November 7, 2023

MX:FLNA Upcoming Earnings

Filana Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-4.41 / -	-3.961	―
Aug 05, 2026	2026 (Q2)	-4.05 / -3.24	-16.564	80.43% (+13.32)
May 07, 2026	2026 (Q1)	-4.14 / -3.78	-8.642	56.25% (+4.86)
Mar 12, 2026	2025 (Q4)	-5.40 / -4.68	-10.263	54.39% (+5.58)
Nov 12, 2025	2025 (Q3)	-4.86 / -3.96	-10.443	62.07% (+6.48)
Aug 14, 2025	2025 (Q2)	- / -16.56	2.341	-807.69% (-18.90)
May 08, 2025	2025 (Q1)	- / -8.64	-7.742	-11.63% (-0.90)
Mar 03, 2025	2024 (Q4)	-10.50 / -10.26	-9.002	-14.00% (-1.26)
Nov 07, 2024	2024 (Q3)	-13.14 / -10.44	-10.983	4.92% (+0.54)
Aug 08, 2024	2024 (Q2)	-7.33 / 2.34	-11.343	120.63% (+13.68)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed